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Microcarriers are microspheres ranging from a few nanometers to some hundreds of
micrometers. One thousand nanometers equal one micrometer which is roughly half a millionth
of an inch. The advantages of using polymeric microcarriers include biodegradability, low
toxicity, and slow release. Microcarriers for drug delivery may be formed from a polyesters such
as poly(lactide-co-glycolide) (PLGA). PLGA microcarriers can successfully be synthesized
through a double emulsion process using sonication. These polyesters degrade in vivo by
hydrolysis of their ester backbone into nontoxic products, which are excreted by the kidneys. The
ratio of lactide to glycolide in the PLGA polymers, the molecular weight and the terminal group
of the PLGA polymer determine how fast drug release occurs. Carboxyl-terminated PLGA
polymers offer faster drug release compared to ester-terminated PLGA.
In order to use microcarriers for a more effective drug delivery, the following hurdles had
to be overcome. First, we had to show that we were able to formulate a consistent protocol for
the production of microparticles. The next hurdle we had to overcome was the encapsulation

process. We had to show that we were able to encapsulate a relatively large compound. Next, we
had to find a way to release the encapsulated molecule. All of these components of making and
releasing a molecule, usually a drug, from a microparticle have to be shown in order to partner
with LUCOM for testing in vivo studies.
A 50:50 acid terminated PLGA was used with polyvinyl alcohol to encapsulate FITCdextrose. We were able to image our microspheres using a confocal microscopy. The use of a
fluorescently tagged sugar allows us to prove that we can successfully encapsulate a relatively
large complex. We next encapsulated immunoglobulin A (IgA), an protein made by the immune
system. We selected IgA because of its size and its importance in the body. To release our
encapsulated molecule, our mircoparticles traveled through a simulation representing the
intestinal system. First, our microparticle were placed in an acidic pH of 2, simulating the
conditions of the stomach. Then, the microparticles were placed into a basic pH of 10.5,
simulating the pH of the intestines. The acidic pH started to break down the PLGA coating, then
when the microparticles reached the basic pH, the drug released.
This proof of concept protocol shows that we were able to encapsulate a relatively large
molecule and have effective release of the molecule into the intestines. This allows for a more
targeted release of a drug, thus allowing scientists to use a lower dosage of drug.

Christian worldview integration: The Christian Gospel is the message of “good news” for how
God has reconciled his image bearers to himself by offering forgiveness through the life, death,
and resurrection of Jesus Christ. Moreover, further pointing to the goodness of creation, in the
incarnation of Jesus, the eternal Son of God became flesh. Those who are in Christ are to be
working against the disorder that exists within the world. The benefits of polymeric nanoparticle

medicine could change the view of medicine in third world countries, where medicine is
expensive and scarce. The Bible tell us in Mark 16:15 to spread the gospel to the whole Earth. If
a nanoparticle that can be developed, by Christian’s, that can be administered to those who have
HIV one will be able to save their life, and the gospel can be shared with them. Also, there is
design in making the nanoparticles. There are many steps that are performed in making a
nanoparticle. Each step has a defined purpose in accomplishing the task of helping the
nanoparticle become biocompatible. An average human cell has a membrane that is both
hydrophilic and hydrophobic. This concept has to be integrated into our nanoparticle. We use
certain polymers, like PLGA, and proteins, like BSA, to create the hydrophobic and hydrophilic
components. God has given us a model, the cell, and has shown us that we are able to replicate
this idea into a new technique for medicine. It is incredible that something that is classified as
“nonliving” can form into an intelligent design to help God’s people.
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